Eli Lilly | LLY - 販売収入





セールス 変化する 日付
AbbVie USD 17.4B 410M 2026-09
Abbott USD 13.01B 423M 2026-09
ALKERMES USD 480.13M 15.88M 2026-09
Amgen USD 10.4B 300M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Baxter International USD 2.98B 20M 2026-09
Biogen USD 2.8B 60M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Coherus Biosciences USD 12.75M 1.18M 2025-12
Drreddys Laboratories INR 86.71B 85.92B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
J&J USD 25.4B 89M 2026-09
Medtronic USD 9.8B 0 2026-06
Merck USD 18.1B 1.5B 2026-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Novo Nordisk DKK 78.49B 18.33B 2026-06
Perrigo USD 989M 31M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 265.71M 15.91M 2026-06
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09
Sanofi EUR 12.3B 160M 2026-06
United Therapeutics USD 832.5M 49.2M 2026-09
Zoetis USD 2.4B 100M 2026-09